Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Common Stock
Class A Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 26, 2019     101,458,000      
Beginning balance at Dec. 26, 2019 $ 764,336   $ 101 $ 370,413 $ (193) $ 394,015
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 2,908     2,908    
Exercise of stock options (in shares)     453,000      
Exercise of stock options 3,783   $ 1 3,782    
Issuance of restricted stock awards (in shares)     368,000      
Shares issued under employee stock purchase plan (in shares)     30,000      
Shares issued under employee stock purchase plan 1,131     1,131    
Other comprehensive gain, net of tax 68       68  
Net income 37,063         37,063
Ending balance (in shares) at Mar. 26, 2020     102,309,000      
Ending balance at Mar. 26, 2020 809,289   $ 102 378,234 (125) 431,078
Beginning balance (in shares) at Dec. 26, 2019     101,458,000      
Beginning balance at Dec. 26, 2019 764,336   $ 101 370,413 (193) 394,015
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive gain, net of tax 160          
Net income 69,067          
Ending balance (in shares) at Jun. 25, 2020     103,147,000      
Ending balance at Jun. 25, 2020 850,496   $ 103 387,344 (33) 463,082
Beginning balance (in shares) at Mar. 26, 2020     102,309,000      
Beginning balance at Mar. 26, 2020 809,289   $ 102 378,234 (125) 431,078
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 4,234     4,234    
Exercise of stock options (in shares)     838,000      
Exercise of stock options 4,877   $ 1 4,876    
Other comprehensive gain, net of tax 92       92  
Net income 32,004         32,004
Ending balance (in shares) at Jun. 25, 2020     103,147,000      
Ending balance at Jun. 25, 2020 850,496   $ 103 387,344 (33) 463,082
Beginning balance (in shares) at Dec. 31, 2020   104,368,212 104,368,000      
Beginning balance at Dec. 31, 2020 997,388   $ 104 408,124 164 588,996
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 4,734     4,734    
Exercise of stock options (in shares)     195,000      
Exercise of stock options 2,383   $ 1 2,382    
Issuance of restricted stock awards (in shares)     27,000      
Forfeiture of restricted stock awards (in shares)     (2,000)      
Issuance of common stock upon vesting of restricted stock units (in shares)     25,000      
Shares issued under employee stock purchase plan (in shares)     26,000      
Shares issued under employee stock purchase plan 1,302     1,302    
Common stock redeemed for tax liability (in shares)     (10,000)      
Common stock redeemed for tax liability (966)     (966)    
Other comprehensive gain, net of tax 83       83  
Net income 75,796         75,796
Ending balance (in shares) at Apr. 01, 2021     104,629,000      
Ending balance at Apr. 01, 2021 1,080,720   $ 105 415,576 247 664,792
Beginning balance (in shares) at Dec. 31, 2020   104,368,212 104,368,000      
Beginning balance at Dec. 31, 2020 $ 997,388   $ 104 408,124 164 588,996
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 603,769          
Other comprehensive gain, net of tax $ 76          
Net income 158,712          
Ending balance (in shares) at Jul. 01, 2021   105,111,284 105,111,000      
Ending balance at Jul. 01, 2021 1,179,602   $ 105 431,549 240 747,708
Beginning balance (in shares) at Apr. 01, 2021     104,629,000      
Beginning balance at Apr. 01, 2021 1,080,720   $ 105 415,576 247 664,792
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 5,319     5,319    
Exercise of stock options (in shares)     409,000      
Exercise of stock options 3,943     3,943    
Issuance of restricted stock awards (in shares)     2,000      
Issuance of common stock upon vesting of restricted stock units (in shares)     2,000      
Shares issued under employee stock purchase plan (in shares)     21,000      
Shares issued under employee stock purchase plan 1,761     1,761    
Issuance of stock related to acquisition (in shares)     50,000      
Issuance of stock related to acquisition 5,000     5,000    
Common stock redeemed for tax liability (in shares)     (1,000)      
Common stock redeemed for tax liability (50)     (50)    
Other comprehensive gain, net of tax (7)       (7)  
Net income 82,916         82,916
Ending balance (in shares) at Jul. 01, 2021   105,111,284 105,111,000      
Ending balance at Jul. 01, 2021 $ 1,179,602   $ 105 $ 431,549 $ 240 $ 747,708